150 credits, with 120 credits in biomedicine, pharmaceutical sciences, drug development, natural sciences and/or engineering, including (1) physical chemistry and pharmaceutics 13 credits or (2) Molecular Biopharmaceutics 7.5 credits. Proficiency in English equivalent to the Swedish upper secondary course English 6.
The course provides an in-depth understanding of nanomedicine and the design of targeted drug delivery systems, with a focus on patient-centered therapies and controlled, selective drug release. You learn to analyse biological, technological, and regulatory aspects of nanotechnology-based formulations, as well as to plan, conduct, and report experimental and project-based work within the field.
